Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01500902 · ClinicalTrials.gov registry record · NA
Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT01500902: Completed NA study, sponsored by Mayo Clinic.
NCT01500902 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01500902, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if testing patients for endothelial dysfunction will help identify which patients are more likely at risk to have another heart attack in the future. Study participants will undergo mental stress testing while at the same time being connected to a device that measures endothelial function via the Endopat device. These same participants will also undergo a sleep study via the Watchpat device.
Interventions
- OTHER EndoPAT testing (non invasive device)
- OTHER WatchPAT testing (non-invasive device)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT01500902 record still lists
NCT01500902 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which EndoPAT testing (non invasive device) is the first listed.
NCT01500902 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01500902 about?
NCT01500902 is a clinical study titled "Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome". The purpose of this study is to determine if testing patients for endothelial dysfunction will help identify which patients are more likely at risk to have another heart attack in the future. Study participants will undergo mental stress testing while at the same time being connected to a device tha...
What is the current status of trial NCT01500902?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2011-09. Estimated completion is 2015-04.
What interventions are being tested in trial NCT01500902?
The interventions under investigation include: EndoPAT testing (non invasive device) (OTHER), WatchPAT testing (non-invasive device) (OTHER).
Who is sponsoring clinical trial NCT01500902?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01500902's enrollment target sits among peer trials
101 840th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia